{
    "clinical_study": {
        "@rank": "53889", 
        "brief_summary": {
            "textblock": "RATIONALE: Bone marrow and peripheral stem cell transplantation may be able to replace\n      immune cells that were destroyed by chemotherapy or radiation therapy used to kill tumor\n      cells.\n\n      PURPOSE: Phase I trial to study the effectiveness of bone marrow and peripheral stem cell\n      transplantation in treating patients who have hematologic cancer."
        }, 
        "brief_title": "Bone Marrow and Peripheral Stem Cell Transplantation in Treating Patients With Hematologic Cancer", 
        "completion_date": {
            "#text": "October 2002", 
            "@type": "Actual"
        }, 
        "condition": [
            "Chronic Myeloproliferative Disorders", 
            "Graft Versus Host Disease", 
            "Leukemia", 
            "Lymphoma", 
            "Multiple Myeloma and Plasma Cell Neoplasm", 
            "Myelodysplastic Syndromes", 
            "Precancerous/Nonmalignant Condition"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Neoplasms", 
                "Graft vs Host Disease", 
                "Leukemia", 
                "Lymphoma", 
                "Lymphoma, Non-Hodgkin", 
                "Multiple Myeloma", 
                "Neoplasms, Plasma Cell", 
                "Plasmacytoma", 
                "Myelodysplastic Syndromes", 
                "Preleukemia", 
                "Myeloproliferative Disorders", 
                "Precancerous Conditions", 
                "Lymphoma, Large-Cell, Immunoblastic"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Determine the toxicity of unmanipulated bone marrow augmented with CD34+ enriched\n           peripheral blood stem cells in patients with hematologic malignancies undergoing\n           allogeneic transplantation.\n\n        -  Evaluate this treatment regimen in terms of kinetics of hematopoietic engraftment,\n           infection, severity of graft-vs-host disease, relapse rate, and cost effectiveness in\n           this patient population.\n\n      OUTLINE: Patients undergo allogeneic transplantation comprising unmanipulated bone marrow\n      with filgrastim (G-CSF)-mobilized, CD34+ enriched peripheral blood stem cells on day 0.\n\n      Patients receive graft-vs-host disease prophylaxis comprising cyclosporine IV over 24 hours\n      on day -1 and methylprednisolone IV or oral prednisone daily on days 7-65. Patients also\n      receive G-CSF subcutaneously daily until blood counts recover.\n\n      Patients are followed weekly for 3 months, at 6 months and 1 year, and then annually for 5\n      years.\n\n      PROJECTED ACCRUAL: A total of 30-60 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Diagnosed hematologic malignancy that is eligible for an active allogeneic bone\n             marrow transplantation protocol and leukemia, lymphoma, myeloma, and aplastic anemia\n             treatment protocols\n\n          -  HLA-identical or one antigen-mismatched related donor\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  10 to 65\n\n        Performance status:\n\n          -  Not specified\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  Not specified\n\n        Hepatic:\n\n          -  Not specified\n\n        Renal:\n\n          -  Not specified\n\n        Other:\n\n          -  No known sensitivity to E. coli derivatives\n\n        PRIOR CONCURRENT THERAPY:\n\n          -  See Disease Characteristics"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "10 Years"
        }, 
        "firstreceived_date": "January 28, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00004232", 
            "org_study_id": "NU FDA96H4", 
            "secondary_id": [
                "NU-96H4", 
                "NCI-G99-1660"
            ]
        }, 
        "intervention": [
            {
                "intervention_name": "filgrastim", 
                "intervention_type": "Biological"
            }, 
            {
                "intervention_name": "cyclosporine", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "methylprednisolone", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "prednisone", 
                "intervention_type": "Drug"
            }, 
            {
                "intervention_name": "allogeneic bone marrow transplantation", 
                "intervention_type": "Procedure"
            }, 
            {
                "intervention_name": "peripheral blood stem cell transplantation", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cyclosporins", 
                "Cyclosporine", 
                "Lenograstim", 
                "Methylprednisolone acetate", 
                "Prednisolone acetate", 
                "Methylprednisolone", 
                "Methylprednisolone Hemisuccinate", 
                "Prednisolone", 
                "Prednisone", 
                "Prednisolone hemisuccinate", 
                "Prednisolone phosphate"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "No", 
        "keyword": [
            "stage I adult Hodgkin lymphoma", 
            "stage II adult Hodgkin lymphoma", 
            "stage III adult Hodgkin lymphoma", 
            "stage IV adult Hodgkin lymphoma", 
            "monoclonal gammopathy of undetermined significance", 
            "recurrent childhood acute lymphoblastic leukemia", 
            "recurrent adult Hodgkin lymphoma", 
            "stage I cutaneous T-cell non-Hodgkin lymphoma", 
            "stage II cutaneous T-cell non-Hodgkin lymphoma", 
            "stage III cutaneous T-cell non-Hodgkin lymphoma", 
            "stage IV cutaneous T-cell non-Hodgkin lymphoma", 
            "recurrent cutaneous T-cell non-Hodgkin lymphoma", 
            "Burkitt lymphoma", 
            "isolated plasmacytoma of bone", 
            "extramedullary plasmacytoma", 
            "refractory multiple myeloma", 
            "stage 0 chronic lymphocytic leukemia", 
            "stage I multiple myeloma", 
            "stage II multiple myeloma", 
            "stage III multiple myeloma", 
            "stage I childhood lymphoblastic lymphoma", 
            "stage II childhood lymphoblastic lymphoma", 
            "stage III childhood lymphoblastic lymphoma", 
            "stage IV childhood lymphoblastic lymphoma", 
            "recurrent childhood lymphoblastic lymphoma", 
            "stage I chronic lymphocytic leukemia", 
            "stage II chronic lymphocytic leukemia", 
            "stage IV chronic lymphocytic leukemia", 
            "recurrent childhood acute myeloid leukemia", 
            "recurrent adult acute myeloid leukemia", 
            "recurrent adult acute lymphoblastic leukemia", 
            "relapsing chronic myelogenous leukemia", 
            "refractory chronic lymphocytic leukemia", 
            "childhood diffuse large cell lymphoma", 
            "childhood immunoblastic large cell lymphoma", 
            "chronic phase chronic myelogenous leukemia", 
            "accelerated phase chronic myelogenous leukemia", 
            "blastic phase chronic myelogenous leukemia", 
            "meningeal chronic myelogenous leukemia", 
            "untreated adult acute lymphoblastic leukemia", 
            "untreated adult acute myeloid leukemia", 
            "untreated childhood acute myeloid leukemia and other myeloid malignancies", 
            "untreated childhood acute lymphoblastic leukemia", 
            "adult acute myeloid leukemia in remission", 
            "adult acute lymphoblastic leukemia in remission", 
            "childhood acute myeloid leukemia in remission", 
            "childhood acute lymphoblastic leukemia in remission", 
            "chronic idiopathic myelofibrosis", 
            "essential thrombocythemia", 
            "untreated hairy cell leukemia", 
            "progressive hairy cell leukemia, initial treatment", 
            "refractory hairy cell leukemia", 
            "stage II childhood Hodgkin lymphoma", 
            "stage I childhood Hodgkin lymphoma", 
            "stage III childhood Hodgkin lymphoma", 
            "stage IV childhood Hodgkin lymphoma", 
            "recurrent/refractory childhood Hodgkin lymphoma", 
            "stage I grade 1 follicular lymphoma", 
            "stage I grade 2 follicular lymphoma", 
            "stage I grade 3 follicular lymphoma", 
            "stage I adult diffuse small cleaved cell lymphoma", 
            "stage I adult diffuse mixed cell lymphoma", 
            "stage I adult diffuse large cell lymphoma", 
            "stage I adult immunoblastic large cell lymphoma", 
            "stage I adult lymphoblastic lymphoma", 
            "stage I adult Burkitt lymphoma", 
            "chronic myelomonocytic leukemia", 
            "T-cell large granular lymphocyte leukemia", 
            "acute undifferentiated leukemia", 
            "stage III grade 1 follicular lymphoma", 
            "stage III grade 2 follicular lymphoma", 
            "stage III grade 3 follicular lymphoma", 
            "stage III adult diffuse small cleaved cell lymphoma", 
            "stage III adult diffuse mixed cell lymphoma", 
            "stage III adult diffuse large cell lymphoma", 
            "stage III adult immunoblastic large cell lymphoma", 
            "stage III adult lymphoblastic lymphoma", 
            "stage III adult Burkitt lymphoma", 
            "stage IV grade 1 follicular lymphoma", 
            "stage IV grade 2 follicular lymphoma", 
            "stage IV grade 3 follicular lymphoma", 
            "stage IV adult diffuse small cleaved cell lymphoma", 
            "stage IV adult diffuse mixed cell lymphoma", 
            "stage IV adult diffuse large cell lymphoma", 
            "stage IV adult immunoblastic large cell lymphoma", 
            "stage IV adult lymphoblastic lymphoma", 
            "stage IV adult Burkitt lymphoma", 
            "recurrent grade 1 follicular lymphoma", 
            "recurrent grade 2 follicular lymphoma", 
            "recurrent grade 3 follicular lymphoma", 
            "recurrent adult diffuse small cleaved cell lymphoma", 
            "recurrent adult diffuse mixed cell lymphoma", 
            "recurrent adult diffuse large cell lymphoma", 
            "recurrent adult immunoblastic large cell lymphoma", 
            "recurrent adult lymphoblastic lymphoma", 
            "recurrent adult Burkitt lymphoma", 
            "stage I adult T-cell leukemia/lymphoma", 
            "stage II adult T-cell leukemia/lymphoma", 
            "stage III adult T-cell leukemia/lymphoma", 
            "stage IV adult T-cell leukemia/lymphoma", 
            "recurrent adult T-cell leukemia/lymphoma", 
            "secondary acute myeloid leukemia", 
            "de novo myelodysplastic syndromes", 
            "previously treated myelodysplastic syndromes", 
            "secondary myelodysplastic syndromes", 
            "graft versus host disease", 
            "prolymphocytic leukemia", 
            "AIDS-related peripheral/systemic lymphoma", 
            "primary systemic amyloidosis", 
            "stage I childhood small noncleaved cell lymphoma", 
            "stage I childhood large cell lymphoma", 
            "stage II childhood small noncleaved cell lymphoma", 
            "stage II childhood large cell lymphoma", 
            "stage III childhood small noncleaved cell lymphoma", 
            "stage III childhood large cell lymphoma", 
            "stage IV childhood small noncleaved cell lymphoma", 
            "stage IV childhood large cell lymphoma", 
            "recurrent childhood small noncleaved cell lymphoma", 
            "recurrent childhood large cell lymphoma", 
            "stage I mantle cell lymphoma", 
            "contiguous stage II grade 1 follicular lymphoma", 
            "contiguous stage II grade 2 follicular lymphoma", 
            "contiguous stage II grade 3 follicular lymphoma", 
            "contiguous stage II adult diffuse small cleaved cell lymphoma", 
            "contiguous stage II mantle cell lymphoma", 
            "contiguous stage II adult diffuse mixed cell lymphoma", 
            "contiguous stage II adult immunoblastic large cell lymphoma", 
            "contiguous stage II adult diffuse large cell lymphoma", 
            "contiguous stage II adult Burkitt lymphoma", 
            "contiguous stage II adult lymphoblastic lymphoma", 
            "noncontiguous stage II grade 1 follicular lymphoma", 
            "noncontiguous stage II grade 2 follicular lymphoma", 
            "noncontiguous stage II grade 3 follicular lymphoma", 
            "noncontiguous stage II adult diffuse small cleaved cell lymphoma", 
            "noncontiguous stage II mantle cell lymphoma", 
            "noncontiguous stage II adult diffuse mixed cell lymphoma", 
            "noncontiguous stage II adult immunoblastic large cell lymphoma", 
            "noncontiguous stage II adult diffuse large cell lymphoma", 
            "noncontiguous stage II adult Burkitt lymphoma", 
            "noncontiguous stage II adult lymphoblastic lymphoma", 
            "stage III mantle cell lymphoma", 
            "stage IV mantle cell lymphoma", 
            "recurrent mantle cell lymphoma", 
            "angioimmunoblastic T-cell lymphoma", 
            "anaplastic large cell lymphoma", 
            "stage I mycosis fungoides/Sezary syndrome", 
            "stage II mycosis fungoides/Sezary syndrome", 
            "stage III mycosis fungoides/Sezary syndrome", 
            "stage IV mycosis fungoides/Sezary syndrome", 
            "recurrent mycosis fungoides/Sezary syndrome", 
            "noncontiguous stage II small lymphocytic lymphoma", 
            "noncontiguous stage II marginal zone lymphoma", 
            "recurrent marginal zone lymphoma", 
            "recurrent small lymphocytic lymphoma", 
            "stage I marginal zone lymphoma", 
            "stage I small lymphocytic lymphoma", 
            "stage III small lymphocytic lymphoma", 
            "stage III marginal zone lymphoma", 
            "stage IV small lymphocytic lymphoma", 
            "stage IV marginal zone lymphoma", 
            "contiguous stage II marginal zone lymphoma", 
            "contiguous stage II small lymphocytic lymphoma", 
            "extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue", 
            "nodal marginal zone B-cell lymphoma", 
            "splenic marginal zone lymphoma", 
            "childhood myelodysplastic syndromes"
        ], 
        "lastchanged_date": "May 31, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60611-3013"
                }, 
                "name": "Robert H. Lurie Comprehensive Cancer Center, Northwestern University"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Augmenting Bone Marrow With CD34 Enriched Peripheral Blood Hematopoietic Stem Cells for Allogeneic Transplantation of Hematologic Malignancies", 
        "overall_official": {
            "affiliation": "Robert H. Lurie Cancer Center", 
            "last_name": "Richard K. Burt, MD", 
            "role": "Study Chair"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Federal Government", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "October 2002", 
            "@type": "Actual"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00004232"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Northwestern University", 
        "sponsors": {
            "collaborator": {
                "agency": "National Cancer Institute (NCI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Northwestern University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 1999", 
        "study_design": "Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "May 2012"
    }, 
    "geocoordinates": {
        "Robert H. Lurie Comprehensive Cancer Center, Northwestern University": "41.878 -87.63"
    }
}